{"doi":"10.21037/gist-21-1","title":"Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: a report of two cases","abstract":"Despite an initial response, most metastatic gastrointestinal stromal tumor (GIST) patients will ultimately be refractory to all current therapies, including imatinib, sunitinib, and regorafenib. Ripretinib at 150 mg daily was recently approved as an additional line of treatment. Few options remain after ripretinib.","journal":"Gastrointestinal Stromal Tumor","year":2021,"id":207525,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":4,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9524,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":793072,"name":"Caroline Hana","orcid":"0000-0002-6663-3535","position":1,"is_corresponding":false},{"id":461311,"name":"Navin Balaji","orcid":"0000-0002-9945-6651","position":2,"is_corresponding":false},{"id":793592,"name":"Anthony Frank Skryd","orcid":null,"position":3,"is_corresponding":false},{"id":793593,"name":"Brianna Nicole Valdes","orcid":null,"position":4,"is_corresponding":false},{"id":793073,"name":"Ramon O. Minjares","orcid":"0000-0001-6943-4040","position":5,"is_corresponding":false},{"id":650325,"name":"Priscila Barreto‐Coelho","orcid":"0000-0002-9236-6071","position":6,"is_corresponding":false},{"id":793074,"name":"Andrea P. Espejo Freire","orcid":"0000-0001-9903-0864","position":7,"is_corresponding":false},{"id":793075,"name":"Muhammad O. Hakim","orcid":"0000-0003-2883-1060","position":8,"is_corresponding":false},{"id":793076,"name":"Emily Jonczak","orcid":"0000-0002-0983-8016","position":9,"is_corresponding":false},{"id":793077,"name":"Ty K. Subhawong","orcid":"0000-0003-0943-1168","position":10,"is_corresponding":false},{"id":227352,"name":"Alan S. Livingstone","orcid":"0000-0003-2102-5795","position":11,"is_corresponding":false},{"id":260070,"name":"Jonathan C. Trent","orcid":"0000-0001-6169-5238","position":12,"is_corresponding":false},{"id":793078,"name":"Gina Z. D’Amato","orcid":"0000-0001-6981-7527","position":13,"is_corresponding":false},{"id":793071,"name":"Philippos Apolinário Costa","orcid":"0000-0001-9681-0515","position":0,"is_corresponding":true}],"reference_count":19,"raw_metadata":null,"created_at":"2026-07-18T23:51:49.715594Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}